Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

797 ARTÍCULOS , VIENDO DEL 106 AL 120

Breaking the Alzheimer's Treatment Stalemate: Synergistic Application Strategies of Nanomaterials and Pharmaceutical Agents

Gao H, Cheng F, Zhang Z, Yan B, Liao P, Zhang S, Li D, Chen F, Lei P.

Mol Neurobiol. 2025 Nov 20;63(1):107. doi: 10.1007/s12035-025-05320-7.

Therapeutic promise of α-hederin in Alzheimer's disease: Insights into inflammation, oxidative stress, and apoptosis modulation

Chettupalli AK, Gupta N, Bukke SPN, Singh MP, Mandal C.

Biomed Pharmacother. 2025 Dec;193:118803. doi: 10.1016/j.biopha.2025.118803. Epub 2025 Nov 22.

The Role of Bacopa monnieri in Alzheimer's Disease: Mechanisms and Potential Clinical Use-A Review

Wiciński M, Fajkiel-Madajczyk A, Wójcicki J, Ozorowski M, Szambelan M.

Nutrients. 2025 Nov 12;17(22):3538. doi: 10.3390/nu17223538.

Therapeutic Applications of Natural Flavonoids Against Alzheimer's Disease-like Pathology: Special Focus on PI3K/Akt and Nrf2 Signaling Pathways

Singh NK, Varshney N.

Curr Neurovasc Res. 2025;22(4):276-295. doi: 10.2174/0115672026423088251205120807.

[Treatment of Alzheimer's disease from gut-brain interactions based on theory of "spleen deficiency leading to obstruction of nine orifices"]

Ma YJ, Deng SX, Liao ZH, Gao MH, Ding HX, Xu ZQ, Lu YT, Yang C, Wang Q.

Zhongguo Zhong Yao Za Zhi. 2025 Oct;50(19):5330-5339. doi: 10.19540/j.cnki.cjcmm.20250618.501.

The Selectivity of Butyrylcholinesterase Inhibitors Revisited

Gambardella MD, Wang Y, Pang J.

Molecules. 2025 Oct 27;30(21):4201. doi: 10.3390/molecules30214201.

Targeting Various Pathogenic Pathways for the Development of Anti-alzheimer's Drugs: An Update

Ambreen S, Fatima N, Umar M, Shaququzzaman M, Alam MM, Ali R.

Curr Top Med Chem. 2025;25(8):826-841. doi: 10.2174/0115680266274924231002110733.

Nanomedicine: A New Frontier in Alzheimer's Disease Drug Targeting

Pathak K, Ahmad MZ, Saikia R, Pathak MP, Sahariah JJ, Kalita P, Das A, Islam MA, Pramanik P, Tayeng D, Abdel-Wahab BA.

Cent Nerv Syst Agents Med Chem. 2025;25(1):3-19. doi: 10.2174/0118715249281331240325042642.

Flavonoids and Alzheimer's disease: reviewing the evidence for neuroprotective potential

Al Amin M, Dehbia Z, Nafady MH, Zehravi M, Kumar KP, Haque MA, Baig MS, Farhana A, Khan SL, Afroz T, Koula D, Tutone M, Nainu F, Ahmad I, Emran TB.

Mol Cell Biochem. 2025 Jan;480(1):43-73. doi: 10.1007/s11010-023-04922-w. Epub 2024 Apr 3.

Graphene Oxide, a Prominent Nanocarrier to Reduce the Toxicity of Alzheimer's Proteins: A Revolution in Treatment

Singh D, Kurmi BD, Singh A.

Recent Pat Nanotechnol. 2025;19(4):572-580. doi: 10.2174/0118722105292940240502114430.

Fyn Kinase in Alzheimer's Disease: Unraveling Molecular Mechanisms and Therapeutic Implications

Meur S, Karati D.

Mol Neurobiol. 2025 Jan;62(1):643-660. doi: 10.1007/s12035-024-04286-2. Epub 2024 Jun 18.

Protective effect of flavonoids on oxidative stress injury in Alzheimer's disease

Wang K, Chen X.

Nat Prod Res. 2025 Mar;39(5):1272-1299. doi: 10.1080/14786419.2024.2345760. Epub 2024 Jun 23.

The Gut Microbiota-Brain Axis: A New Frontier in Alzheimer's Disease Pathology

Dhanawat M, Malik G, Wilson K, Gupta S, Gupta N, Sardana S.

CNS Neurol Disord Drug Targets. 2025;24(1):7-20. doi: 10.2174/0118715273302508240613114103.

Melatonin: A potential nighttime guardian against Alzheimer's

Zhang Z, Xue P, Bendlin BB, Zetterberg H, De Felice F, Tan X, Benedict C.

Mol Psychiatry. 2025 Jan;30(1):237-250. doi: 10.1038/s41380-024-02691-6. Epub 2024 Aug 11.

Exploring the Mechanisms and Therapeutic Approaches of Mitochondrial Dysfunction in Alzheimer's Disease: An Educational Literature Review

Moawad MHED, Serag I, Alkhawaldeh IM, Abbas A, Sharaf A, Alsalah S, Sadeq MA, Shalaby MMM, Hefnawy MT, Abouzid M, Meshref M.

Mol Neurobiol. 2025 Jun;62(6):6785-6810. doi: 10.1007/s12035-024-04468-y. Epub 2024 Sep 10.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias